Crossmark

CA-125:CA72-4 ratio − towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment

Crossref DOI link: https://doi.org/10.1186/s13048-024-01487-0

Published Online: 2024-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Margoni, Angeliki

Gargalionis, Antonios N.

Papavassiliou, Athanasios G.
License Information

Text and Data Mining valid from 2024-08-10

Version of Record valid from 2024-08-10
More Information

Article History

Received: 15 July 2024

Accepted: 5 August 2024

First Online: 10 August 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below